Company: LENZ
Filing Date: 2025-04-04
Form Type: POS AM
Source: 0001628280-25-016813
Chunk: 29

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-04
Form: POS AM
Chunk 29
---
.5 to the Company’s Registration Statement on Form S-4 filed with the SEC on December 6, 2023).                                                                               |
| 5.1     |     | Opinion of Wilson Sonsini Goodrich & Rosati, P.C. (incorporated by reference to Exhibit 5.1 to the Company’s Registration Statement on Form S-1 (File No. 333-278393) filed with the SEC on April 9, 2024.                                                                          |
| 10.1    |     | Subscription Agreement, dated November 14, 2023, by and among Graphite Bio, Inc. and certain parties thereto (incorporated by reference to Exhibit 10.4 to the Company’s Form 8-K filed with the SEC on November 15, 2023).                                                         |
| 10.2    |     | Registration Rights Agreement, dated March 21, 2024, by and among LENZ Therapeutics, Inc. and certain parties thereto (incorporated by reference to Exhibit 10.21 to the Company’s Current Report on Form 8-K filed with the SEC on March 22, 2024).                                |
| 23.1    |     | Consent of Independent Registered Public Accounting Firm.                                                                                                                                                                                                                           |
| 23.2    |     | Consent of Wilson Sonsini Goodrich & Rosati, P.C. (included in Exhibit 5.1).                                                                                                                                                                                                        |
| 24.1    |     | Power of Attorney (included on signature page to the Company’s Registration Statement on Form S-1 (File No. 333-278393) filed with the SEC on March 29, 2024.                                                                                                                       |

__________________

† Schedules and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.

(2)

#### Financial Statement Schedules
. All financial statement schedules are omitted because the information called for is not required or is shown either in the consolidated financial statements or in the notes thereto.

<div align='center'>II-2</div>

## ITEM 17. UNDERTAKINGS.
(1) The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by section 10